Niagen Bioscience, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2012 | 19.6% | -100.2% | -100.4% |
| FY2013 | 30.8% | -43.2% | -43.5% |
| FY2015 | 34.8% | -34.2% | -35.2% |
| FY2016 | 48.0% | -13.4% | -13.5% |
| FY2017 | 49.4% | -77.2% | -53.7% |
| FY2018 | 50.9% | -105.1% | -105.6% |
| FY2019 | 55.7% | -67.6% | -69.4% |
| FY2020 | 59.5% | -33.5% | -33.6% |
| FY2021 | 61.5% | -40.1% | -40.2% |
| FY2022 | 59.4% | -25.9% | -23.0% |
| FY2023 | 60.8% | -6.7% | -5.9% |
| FY2024 | 61.8% | 7.8% | 8.6% |
| FY2025 | 64.3% | 12.6% | 13.4% |